![Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B | Scientific Reports Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-56015-8/MediaObjects/41598_2019_56015_Fig1_HTML.png)
Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B | Scientific Reports
![Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation - The Lancet Global Health Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation - The Lancet Global Health](https://www.thelancet.com/cms/asset/98b68206-6c50-4fc6-9239-e0ca50c807a2/gr1.jpg)
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation - The Lancet Global Health
![Viruses | Free Full-Text | Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy Viruses | Free Full-Text | Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy](https://www.mdpi.com/viruses/viruses-13-01691/article_deploy/html/images/viruses-13-01691-g001.png)